Cancer Vaccines Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027
The Global Cancer Vaccines Market should grow from $8.1 billion in 2021 to $11.7 billion by 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2021-2027.
Cancer vaccines are drugs that are considered biological response modifiers. These biological response modifiers work by stimulating the body’s immune system to fight cancer. Prophylactic cancer vaccines and therapeutic cancer vaccines are two types of cancer vaccines. Preventive cancer vaccines are used in healthy people to prevent cancer. Therapeutic cancer vaccines are used by cancer patients to boost their immune response to fight disease. Cancer vaccines can be given intravenously (IV) to children as well as adults.
Market Segments
By treatment method:
- Preventive cancer vaccines
- Therapeutic cancer vaccines
By type:
- Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Viral Vector and DNA Vaccines
- Others
By application:
- Cervical cancer
- Prostate cancer
- Lung cancer
- Breast cancer
- Others
Key Players
The key players profiled in this report include Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc (GSK), Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Sanpower Group Co. Ltd. (Dendereon Corporation), UbiVac, and Vaccinogen, Inc.
Scope of the Report
The research study analyzes the global Cancer Vaccines industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Cancer Vaccines Market Report
1. What was the Cancer Vaccines Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Cancer Vaccines Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Cancer Vaccines Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation